Dashyant Dhanak's most recent trade in Deciphera Pharmaceuticals Inc was a trade of 69,100 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 15, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Deciphera Pharmaceuticals Inc | Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 69,100 | 69,100 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 17,275 | 158,175 (0%) | 0% | 0 | Common Stock | |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 16,896 | 16,896 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 8,056 | 58,968 (0%) | 0% | 0 | Common Stock | |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.08 per share. | 03 Jul 2023 | 6,044 | 50,912 (0%) | 0% | 62.1 | 375,212 | Common Stock |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 3,693 | 0 | - | - | Incentive Stock Option (right to buy) | |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.42 per share. | 16 Feb 2023 | 3,693 | 56,956 (0%) | 0% | 65.4 | 241,596 | Common Stock |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 26 Jan 2023 | 2,419 | 53,263 (0%) | 0% | 85 | 205,615 | Common Stock |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 16,128 | 16,128 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,980 | 55,682 (0%) | 0% | 0 | Common Stock | |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.36 per share. | 12 Dec 2022 | 533 | 50,702 (0%) | 0% | 82.4 | 43,898 | Common Stock |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 15,277 | 15,277 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 11,274 | 53,416 (0%) | 0% | 0 | Common Stock | |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.25 per share. | 02 Jul 2022 | 2,181 | 51,235 (0%) | 0% | 79.2 | 172,844 | Common Stock |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 8,678 | 42,142 (0%) | 0% | 0 | Common Stock | |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.40 per share. | 10 Dec 2021 | 533 | 33,464 (0%) | 0% | 65.4 | 34,858 | Common Stock |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 2,355 | 33,997 (0%) | 0% | 0 | Common Stock | |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 379 | 31,642 (0%) | 0% | 0 | Common Stock | |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 68.67 per share. | 01 Oct 2021 | 389 | 31,263 (0%) | 0% | 68.7 | 26,713 | Common Stock |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 76.71 per share. | 01 Sep 2021 | 388 | 31,652 (0%) | 0% | 76.7 | 29,763 | Common Stock |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 77.49 per share. | 02 Aug 2021 | 389 | 32,040 (0%) | 0% | 77.5 | 30,144 | Common Stock |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 7,853 | 34,002 (0%) | 0% | 0 | Common Stock | |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.58 per share. | 02 Jul 2021 | 1,573 | 32,429 (0%) | 0% | 83.6 | 131,471 | Common Stock |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 84.09 per share. | 01 Jul 2021 | 396 | 26,149 (0%) | 0% | 84.1 | 33,300 | Common Stock |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 84.13 per share. | 01 Jun 2021 | 395 | 26,545 (0%) | 0% | 84.1 | 33,231 | Common Stock |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 85.40 per share. | 03 May 2021 | 396 | 26,940 (0%) | 0% | 85.4 | 33,818 | Common Stock |
| Incyte | Dashyant Dhanak | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 81.57 per share. | 01 Apr 2021 | 396 | 27,336 (0%) | 0% | 81.6 | 32,302 | Common Stock |